Market Overview:
The global RNase A market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for nucleic acid purification and synthetic biology applications. North America is expected to dominate the global RNase A market during the forecast period, followed by Europe and Asia Pacific.
Product Definition:
RNase A is a protein that helps to break down RNA. It is important for the digestion of food and for the removal of unwanted material from the body.
RNase A In Solution:
RNase A is an enzyme that catalyzes the hydrolysis of RNA in solution. It's major use is in DNA extraction, but it has a few other applications as well. The usage of RNase A increases when there are problems with the DNA isolation procedure such as contamination or if the sample needs to be tested for genetic material.
RNase A In Lyophilized Powde:
RNase A is a protein-based, enzyme that catalyzes the hydrolysis of RNA into nucleotides. It is commercially available in lyophilized powder form and can be reconstituted with deionized water or physiological saline solution for use in various diagnostic assays.
Application Insights:
The application segment is segregated into nucleic acid purification and synthetic biology. In 2017, the nucleic acid purification dominated the overall market in terms of revenue share at over 60%. This is attributed to rising demand for genomic and proteomic research coupled with an increase in spending on genomics-based therapeutics.
The rise in demand for purified products has been further augmented by technological advancements that have led to a significant reduction in costs associated with production of these products. Synthetic biology also had a considerable market share owing to its potential applications such as genetic engineering of bacteria and viruses that can be used for therapeutic purposes as well as production of biofuels, biochemicals and bioelectronics devices.
Regional Analysis:
North America dominated the global market in 2017. This is attributed to the presence of a well-established biotechnology industry, government funding for R&D in genomics and proteomics, and high disposable income of consumers. Moreover, increasing prevalence of chronic diseases such as cancer and diabetes is expected to boost demand for diagnostic tests that involve purification or isolation of nucleic acids from biological samples.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to factors such as growing healthcare spending by governments along with rising investments by pharmaceutical companies in this region due to availability of untapped opportunities relatedto drug discovery & development coupled with low manufacturing cost associated with Asian countries than other developed nations globally. These aforementioned factors are expectedto contribute toward regional growth during the forecast period from 2018 To 2030 as RNase A has been used traditionallyin Japan for protein purification applications followed by U.S.
Growth Factors:
- Increasing demand for RNA-based therapeutics and diagnostics
- Growing application of RNase A in life science research
- Rising prevalence of chronic diseases
- Technological advancements in RNA sequencing and analysis tools
- Growing investments in life science research
Scope Of The Report
Report Attributes
Report Details
Report Title
RNase A Market Research Report
By Type
RNase A In Solution, RNase A In Lyophilized Powde
By Application
Nucleic Acid Purification, Synthetic Biology
By Companies
Thermo Fisher Scientific, QIAGEN, Merck, Beyotime, NEB, Promega, Canvax, Worthington Biochemical, Carl ROTH, Bio Basic, AG Scientific, Jena Bioscience, Yeasen Biotech, Gold Biotechnology, Geneaid, Omega Bio-Tek, Rockland Immunochemicals, BioVision, LGC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
175
Number of Tables & Figures
123
Customization Available
Yes, the report can be customized as per your need.
Global RNase A Market Report Segments:
The global RNase A market is segmented on the basis of:
Types
RNase A In Solution, RNase A In Lyophilized Powde
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Nucleic Acid Purification, Synthetic Biology
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- QIAGEN
- Merck
- Beyotime
- NEB
- Promega
- Canvax
- Worthington Biochemical
- Carl ROTH
- Bio Basic
- AG Scientific
- Jena Bioscience
- Yeasen Biotech
- Gold Biotechnology
- Geneaid
- Omega Bio-Tek
- Rockland Immunochemicals
- BioVision
- LGC
Highlights of The RNase A Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- RNase A In Solution
- RNase A In Lyophilized Powde
- By Application:
- Nucleic Acid Purification
- Synthetic Biology
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the RNase A Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
RNase A is an enzyme that breaks down RNA.
Some of the major players in the rnase a market are Thermo Fisher Scientific, QIAGEN, Merck, Beyotime, NEB, Promega, Canvax, Worthington Biochemical, Carl ROTH, Bio Basic, AG Scientific, Jena Bioscience, Yeasen Biotech, Gold Biotechnology, Geneaid, Omega Bio-Tek, Rockland Immunochemicals, BioVision, LGC.
The rnase a market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 RNase A Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 RNase A Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 RNase A Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the RNase A Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global RNase A Market Size & Forecast, 2020-2028
4.5.1 RNase A Market Size and Y-o-Y Growth
4.5.2 RNase A Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 RNase A In Solution
5.2.2 RNase A In Lyophilized Powde
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Nucleic Acid Purification
6.2.2 Synthetic Biology
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global RNase A Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 RNase A Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 RNase A In Solution
9.6.2 RNase A In Lyophilized Powde
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Nucleic Acid Purification
9.10.2 Synthetic Biology
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 RNase A In Solution
10.6.2 RNase A In Lyophilized Powde
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Nucleic Acid Purification
10.10.2 Synthetic Biology
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 RNase A In Solution
11.6.2 RNase A In Lyophilized Powde
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Nucleic Acid Purification
11.10.2 Synthetic Biology
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 RNase A In Solution
12.6.2 RNase A In Lyophilized Powde
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Nucleic Acid Purification
12.10.2 Synthetic Biology
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 RNase A In Solution
13.6.2 RNase A In Lyophilized Powde
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Nucleic Acid Purification
13.10.2 Synthetic Biology
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 RNase A Market: Competitive Dashboard
14.2 Global RNase A Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 QIAGEN
14.3.3 Merck
14.3.4 Beyotime
14.3.5 NEB
14.3.6 Promega
14.3.7 Canvax
14.3.8 Worthington Biochemical
14.3.9 Carl ROTH
14.3.10 Bio Basic
14.3.11 AG Scientific
14.3.12 Jena Bioscience
14.3.13 Yeasen Biotech
14.3.14 Gold Biotechnology
14.3.15 Geneaid
14.3.16 Omega Bio-Tek
14.3.17 Rockland Immunochemicals
14.3.18 BioVision
14.3.19 LGC
